ALLO Operating Cash Flow (Statement)
Allogene Therapeutics Inc · Operating Cash Flow (Statement)
ALLO Operating Cash Flow (Statement)
Latest reported-$102.20Mperiod ending
ALLO Cash from Operations ($0.00 → -$102.20M)
Annual operating cash flow (statement)
High-resolution chart · PNG
ALLO operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -149,246,000 | |
| -200,300,000 | |
| -237,733,000 | |
| -220,519,000 | |
| -184,812,000 | |
| -115,093,000 | |
| -137,350,000 | |
| -44,653,000 | |
| 0 |